Top 5 Biotechnology companies in Coimbrã, Leiria, Portugal

INFOGENE

Infogene is a portuguese start-up company that develops and markets innovative non-invasive ways of detecting cancer as early as possible, generating value from providing information concerning heath status, preventing cancer death and reducing costs in healthcare. The company has developed a non invasive home-brew test for the detection of the Human Papilloma Virus (HPV), the most common cause of cervical cancer, and a test for detection of colorectal and uterus cancer. The alternative to the common Pap test for HP-Virus detection was be launched on September 2007. Infogene has been awarded important entrepreneurship and innovation prizes in the last years: - Bio-entrepreneur of the year 2006 - by ApBio - "Innovation prize in Health, Personal Care and Attendance - BES prize 2007€ - "BES Innovation Award 2007 - Premio BES inovacao do ano 2007" - "Finalist of Young entrepreneur of the year 2008 - by ANJE 2008" - This year, the R&D (Research & Development) Unit of Infogene has been awarded a QREN grant funding for the development of new projects.

LaserLeap Technologies

LaserLeap Tecnhologies was established to address the need for a painless method to deliver medicines through the skin, and promote faster and more effective treatments. Two decades of research with lasers and ultrasound led to a technology that combines affordable lasers with innovative materials, and is capable of permeabilizing the skin to medicines and cosmetics in a safe, painless and effective manner. Established on 2011 in Coimbra, Portugal, the company focuses in the skin permeation of cosmetics, anesthetics, drugs for skin cancer, vaccines and biotechnology drugs.

MitoDIETS

MitoDIETS develops targeting systems that deliver antioxidants to the cellular energy sources for use in cosmetics, human health and veterinary. MitoDIETS is a Portuguese startup that develops targeting systems to deliver antioxidants to the cellular energy sources in order to protect them from the damaging effects of oxidation. This platform technology has applications in diverse areas, namely: as active ingredients for anti-aging cosmetics, active principles for the treatment of liver and neurodegenerative diseases, as well as anti-aging food supplements for pets. Unlike current market solutions, the enhanced natural antioxidants developed by MitoDIETS are able to target specific cellular organelles called mitochondria, achieving up to 5000 times greater accumulation when compared to traditional antioxidants. This ensures a much more powerful and specific antioxidant action, thus preventing and minimizing the undesirable effects of oxidative stress, a major cause of aging- and lifestyle-related complications and metabolic disorders. MitoDIETS has participated in this year’s Ineo Start by IPN and COHiTEC by COTEC entrepreneurship programs and was one of the winners of the Road 2 Web Summit contest, promoted by Portugal Ventures, that awarded 67 promising startups the chance to represent Portugal in the Web Summit.

Twitter | Facebook | LinkedIn

Vetherapy

Vetherapy is a biotech company founded in 2015, that operates in the field of Veterinary Regenerative Medicine and Tissue Engineering, developing products with great therapeutical potencial, based on stem cells, platelet-rich plasma (PRP) and biomaterials. They offer quality and safety in the processes of isolation, expansion, and cryopreservation of stem cells, as well as obtaining plasma rich in growth factors, thus providing safe and efficient products for the treatment of different pathologies in our animals. They enable veterinarians to access our stem cell and PRP bank through our cryopreservation services. This way, their products are always available and ready to use for immediate treatment, thus answering different clinical situations.

Facebook | LinkedIn

Treat U

TREAT U is dedicated to the development of targeted nanotechnology-based platforms for the specific delivery of drugs (either small drugs or siRNA) with technological advantages that outrun different products commercially available or in clinical trials, namely in the Oncology area. TREAT U’s platforms are an appealing technology for the Pharmaceutical Industry (costumer) for the reason that brings value to patients, physicians and the healthcare system (end-users). The market strategy of TREAT U is to out-license proprietary technology to Pharmaceutical companies, as soon as Phase I or Phase II clinical testing is concluded. TREAT U has gathered a team with competencies on the design and development of nanotechnology-based platforms, pharmacology, drug development, clinical trials and business development, thus addressing the different needs requested within the medicines value chain.

Twitter | Facebook